Sanofi India Limited Stock Price Today (NSE: SANOFI)
Fundamental Score
Sanofi India Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sanofi India Limited share price today is ₹3209.70, down 3.82% on NSE/BSE as of 30 March 2026. Sanofi India Limited (SANOFI) is a Mid-cap company in the Pharmaceuticals sector with a market capitalisation of ₹10.03K (Cr). The 52-week high for SANOFI share price is ₹6717.00 and the 52-week low is ₹3160.00. At a P/E ratio of 27.17x, SANOFI is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 47.15% and a debt-to-equity ratio of 0.03.
Sanofi India Limited Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Sanofi India Limited Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Sanofi Share Price: A Financial Stability Analysis
The pharmaceutical sector, often characterized by significant research and development investments coupled with stringent regulatory oversight, presents a unique risk-reward profile for investors. This analysis focuses on the financial stability of Sanofi India Limited, examining the current Sanofi share price of ₹4000.89990234375. Our assessment considers key financial metrics and comparative analysis against its sector peers to provide an observational overview. This is part of a comprehensive 80-parameter fundamental audit process, verified by Sweta Mishra, to enhance rigor.
The current Price-to-Earnings (PE) ratio for Sanofi stands at 27.17. While this indicates the amount investors are willing to pay for each rupee of earnings, it's essential to compare it with its peers. For instance, when evaluating against
Mankind Pharma Ltd, aspects beyond pure numbers, such as perceived management quality and future growth expectations, play a crucial role in determining fair value. While we cannot definitively state the quality, evaluating management effectiveness through public information, track record, and strategic decisions will provide insights into the long-term sustainability of the company's performance.A particularly noteworthy aspect of Sanofi's financial health is its impressive Return on Capital Employed (ROCE) of 49.16%. ROCE is a profitability ratio that gauges how well a company is generating profits from its capital. A high ROCE, such as Sanofi's, suggests efficient capital allocation and strong operational performance. This robust ROCE contributes significantly to building the company's economic moat, making it more difficult for competitors like
Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd to erode Sanofi's market position and profitability. In essence, the high ROCE provides Sanofi with a substantial competitive advantage.In conclusion, this analysis presents an observational view of Sanofi's financial stability based on publicly available data. While the current Sanofi share price reflects certain investor expectations, factors like management quality and the sustainability of its high ROCE will be critical in determining its long-term performance. This assessment is purely for informational purposes and should not be construed as investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sanofi India Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SANOFI across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (47.15%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (49.16%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (25.01%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Conservative Debt Levels (D/E: 0.03)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (336.47x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹2441.60 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (60.40%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Strong Institutional Confidence (FII+DII: 27.85%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Revenue Contraction (-9.27%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-8.10% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-0.44% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-0.44% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Sanofi India Limited Financial Statements
Comprehensive financial data for Sanofi India Limited including income statement, balance sheet and cash flow
About SANOFI (Sanofi India Limited)
Sanofi India Limited is a prominent player in the Indian pharmaceutical landscape, committed to advancing healthcare solutions that cater to diverse medical needs. With a robust po...rtfolio spanning various therapeutic areas, the company focuses on delivering innovative and high-quality medicines to patients across India and select international markets. Sanofi India blends its global expertise with a deep understanding of local healthcare challenges, enabling it to address unmet medical needs and contribute to improved patient outcomes. Through strategic collaborations, research and development initiatives, and a dedicated workforce, Sanofi India strives to strengthen its position as a trusted partner in healthcare, promoting wellness and enhancing the quality of life for individuals and communities. The company's dedication to innovation and patient-centricity is reflected in its diverse product offerings. Focusing on areas such as metabolic disorders, cardiovascular diseases, and central nervous system disorders, Sanofi India provides a range of prescription drugs and consumer healthcare products designed to manage chronic conditions and address acute illnesses. Sanofi India endeavors to provide holistic healthcare solutions that improve patient adherence, efficacy, and accessibility. The company invests in cutting-edge technologies and advanced manufacturing processes to ensure the highest standards of quality and safety. With a strong commitment to ethical business practices and regulatory compliance, Sanofi India operates with integrity and transparency, building trust and confidence among healthcare professionals, patients, and stakeholders. Sanofi India remains committed to expanding its reach and impact through strategic partnerships and collaborations. By forging alliances with leading research institutions, healthcare providers, and industry organizations, the company aims to accelerate the development and commercialization of innovative therapies. Sanofi India's goal is to contribute to the advancement of medical knowledge and improve patient care in India and beyond. The company also places a strong emphasis on sustainable business practices, environmental responsibility, and social impact, demonstrating its commitment to creating a healthier and more equitable future for all. Sanofi India strives to be a responsible corporate citizen, contributing to the economic and social well-being of the communities in which it operates.
Company Details
Key Leadership
Corporate Events
SANOFI Share Price: Frequently Asked Questions
What is the current share price of Sanofi India Limited (SANOFI)?
As of 30 Mar 2026, 12:07 pm IST, Sanofi India Limited share price is ₹3209.70. The SANOFI stock has a market capitalisation of ₹10.03K (Cr) on NSE/BSE.
Is SANOFI share price Overvalued or Undervalued?
SANOFI share price is currently trading at a P/E ratio of 27.17x, compared to the industry average of 31.77x. Based on this relative valuation, the Sanofi India Limited stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of SANOFI share price?
The 52-week high of SANOFI share price is ₹6717.00 and the 52-week low is ₹3160.00. These values are updated daily from NSE/BSE price data.
What factors affect the Sanofi India Limited share price?
Key factors influencing SANOFI share price include quarterly earnings growth (Sales Growth: -9.27%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Sanofi India Limited a good stock for long-term investment?
Sanofi India Limited shows a 5-year Profit Growth of -0.44% and an ROE of 47.15%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.03 before investing in SANOFI shares.
How does Sanofi India Limited compare with its industry peers?
Sanofi India Limited competes with major peers in the Pharmaceuticals. Investors should compare SANOFI share price P/E of 27.17x and ROE of 47.15% against the industry averages to determine competitive standing.
What is the P/E ratio of SANOFI and what does it mean?
SANOFI share price has a P/E ratio of 27.17x compared to the industry average of 31.77x. Investors pay ₹27 for every ₹1 of annual earnings.
How is SANOFI performing according to Bull Run's analysis?
SANOFI has a Bull Run fundamental score of 49/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does SANOFI belong to?
SANOFI operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Sanofi India Limited share price.
What is Return on Equity (ROE) and why is it important for SANOFI?
SANOFI has an ROE of 47.15%, which indicates excellent management efficiency. ROE measures how efficiently Sanofi India Limited generates profits from shareholders capital.
How is SANOFI debt-to-equity ratio and what does it indicate?
SANOFI has a debt-to-equity ratio of 0.03, which indicates conservative financing with low financial risk.
What is SANOFI dividend yield and is it a good dividend stock?
SANOFI offers a dividend yield of 2.68%, meaning you receive ₹2.68 annual dividend for every ₹100 invested in Sanofi India Limited shares.
How has SANOFI share price grown over the past 5 years?
SANOFI has achieved 5-year growth rates of: Sales Growth -8.10%, Profit Growth -0.44%, and EPS Growth -0.44%.
What is the promoter holding in SANOFI and why does it matter?
Promoters hold 60.40% of SANOFI shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Sanofi India Limited.
What is SANOFI market capitalisation category?
SANOFI has a market capitalisation of ₹10033 crores, placing it in the Mid-cap category.
How volatile is SANOFI stock?
SANOFI has a beta of N/A. A beta > 1 suggests the Sanofi India Limited stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is SANOFI operating profit margin trend?
SANOFI has a 5-year average Operating Profit Margin (OPM) of 25.01%, indicating the company's operational efficiency.
How is SANOFI quarterly performance?
Recent quarterly performance shows Sanofi India Limited YoY Sales Growth of -9.27% and YoY Profit Growth of 15.54%.
What is the institutional holding pattern in SANOFI?
SANOFI has FII holding of 5.57% and DII holding of 22.28%. Significant institutional holding often suggests professional confidence in the Sanofi India Limited stock.